资讯

Blueprint Medicines Presents Strong Long-Term Data for AYVAKIT in Systemic Mastocytosis
Blueprint Medicines Corporation (NASDAQ:BPMC) is one of the best biotech stocks to invest in now. On June 12, Blueprint ...